MBM-17 Catalog No.:M23695-C has been identified as a

has been identified as a potential target for therapeutic agents in the treatment of various medical conditions

and cardiac stimulating activities

COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2C(C)=CC=CC=2C)CC1

Ther Adv Musculoskelet Dis

The inhibitory activities of BTM-1086 are significantly higher than those of atropine sulfate

MBM-17 Catalog No.:M23695-C has been identified as aMBM 17 is a potent NIMA related kinase 2 (Nek2) inhibitor with an IC50 of 3 nM. It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM 55 shows antitumor activities, and no obvious toxicity to mice. Product information CAS Number: 2083621 90 1 Molecular Weight: 480. 56 Formula: C28H28N6O2 Chemical Name: 2 (benzyloxy) 4 (7 {1 [2 (dimethylamino)ethyl] 1H pyrazol 4 yl}imidazo[1,2 a]pyridin 3